Among the top 6 globally administered vaccines, up to 36% of their effective shelf-life is lost due to poor cold chain management. No physician wants to be in the position of administering a vaccine that may have been compromised by exposure to the wrong temperature.
World Adopt Summit: Interview with MedCision CEO, Rolf Ehrhardt
Rolf Ehrhardt, MD, PhD
Standardization and automation are going to be key in order for these therapies to move into a global market and ensure that patient demand can be met. Too often we see pharmaceutical developers put an enormous effort into ensuring efficacy and safety of their product.